Alexander Capron

University Professor, Scott H. Bice Chair in Healthcare Law, Policy and Ethics, Professor of Law and Medicine, Keck School of Medicine, Co-Director, Pacific Center for Health Policy and EthicsUSC Gould School of Law

Alexander Capron
Work: (213) 740-2557
699 Exposition Blvd. Los Angeles, CA 90089-0074 USA Room: 450

Download vCard
Download Curriculum Vitae

last updated Tue, Jul 9, 2013

Alexander Capron is a globally recognized expert in health policy and medical ethics. He teaches Public Health Law, Torts, and Law, Science, and Medicine. He also teaches at the USC Keck School of Medicine and is co-director of the Pacific Center for Health Policy and Ethics, a campus-wide interdisciplinary research and education center. He returned to USC Law in fall 2006 after four years on leave as director of Ethics, Trade, Human Rights and Health Law at the World Health Organization in Geneva.

Prof. Capron’s publications include Ethical Issues in Governing Biobanks: Global Perspectives (with others, Ashgate, 2008), Law, Science and Medicine 2nd ed. (with others, Foundation Press, 1996), Treatise on Health Care Law (with others, Matthew Bender, 1991), and Genetics, Ethics and Human Values (edited with Z. Bankowski, Geneva: CIOMS, 1991).

Prof. Capron received a B.A. from Swarthmore College and an LL.B. from Yale University, where he was an officer of the Yale Law Journal. He was appointed by President Bill Clinton to the National Bioethics Advisory Commission, and served as President of the International Association of Bioethics. Prof. Capron is a trustee of The Century Foundation, an officer of Public Responsibility in Medicine and Research, and an elected member of the Institute of Medicine (National Academy of Sciences) and of the American Law Institute.
 

Works in Progress

  • Combating Organ Trafficking and Transplant Tourism: The Impact of the Declaration of Istanbul Thus Far.
  • Definition of Death, in Encyclopedia of Applied Ethics (R. Chadwick, ed., forthcoming, 2010).
  • Rethinking Informed Consent in Research: The Beecher Lecture (2011).
  • Determining Death: Settled or Unsettled?

Books

  • Casebook on Ethical Issues in International Health Research (with R. Cash, D. Wikler, & A. Saxena) (Geneva: World Health Organization, 2009).
  • International Ethical Guidelines for Epidemiological Studies, Council for International Organizations of Medical Sciences, (Geneva: CIOMS, 2008) (A.M. Capron, principal rapporteur).
  • Ethical Issues in Governing Biobanks: Global Perspectives (edited with B. Elger, N. Biller-Andorno, & A. Mauron) (London: Ashgate, 2008).
  • Treatise on Health Care Law (with others) (Matthew Bender, 1991, with semi-annual updates).
  • Genetics, Ethics and Human Values (edited with Z. Bankowski) (Geneva: CIOMS, 1991).
  • Patient Outcome Research Teams: Managing Conflict of Interest (edited with Molla S. Donaldson) (National Academy Press, 1991).
  • Ethics and Human Values in Family Planning (edited with Z. Bankowski and J. Barzelatto) (Geneva: CIOMS, 1989
  • Law, Science and Medicine (with others) (Foundation Press, 1984; Supplement, 1987 and 1989; 2d ed., 1996).
  • Disclosure and Consent: Decisionmaking in Physician-Patient and Lawyer-Client Interactions (with J. Katz) (Yale Law School, 1980).
  • Genetic Counseling: Facts, Values, and Norms (joint editor) (A.R. Liss, 1979).
  • Catastrophic Diseases -- Who Decides What? (with J. Katz) (Russell Sage Foundation, 1975; paperback, Transaction Books, 1978, 1982).
  • Genetic Screening: Programs, Principles, and Research (with others) (National Academy of Sciences, 1975).
  • Experimentation with Human Beings: The Authority of the Investigator, Subject, Professions and State in Human Experimentation (J. Katz with assistance of A.M. Capron and E.S. Glass). (Russell Sage Foundation, 1972).

Articles and Book Chapters

  • "The Circulatory-Respiratory Determination of Death in Organ Donation" (with J.L. Bernat, A.M. Capron, et. al.), 38 Critical Care Medicine 963-970 (2010).
  • "The Governance of Scientific Collaborations: The International Reach of U.S. Law" in M. Anderson & N. Steneck, eds., International Research Collaborations: Much to Gain, Many Ways to Get in Trouble 97-104 (New York: Routledge, 2010).
  • "American Law and the Governance of Research Ethics," 22 Singapore Acad. L. J. 769-84 (2010).
  • "Advance Directives," in P. Singer & H. Kuhse, eds., A Companion to Bioethics, Second Edition 299-311 (London & New York: Blackwell, 2009).
  • “Ethical Norms and the International Governance of Genomics: Findings from an International Study” (with A. Mauron, B. Elger, A. Boggio, A. Ganguli Mitra & N. Biller-Andorno),19 Kennedy Institute of Ethics Journal 101 (2009).
  • “The Legacy of Jay Katz: The Abiding Relevance of the “Obligation for Conversation” in the Physician-Patient Relationship”, 2 J. of Health and Life Sciences Law 3-6 (2009).
  • “Legalizing Physician-Assisted Suicide”, in R. Sadoff, ed., Issues in Pharmacy, Law and Ethics, Ch. 3, pp. 35-50 (Minneapolis: University of Minnesota, 2008).
  • “Legal and Regulatory Standards of Informed Consent in Research”, in E. Emanuel et al., eds, The Oxford Textbook of Clinical Research Ethics Ch. 57, pp. 613-32 (New York: Oxford University Press, 2008).
  • “Organ trafficking and transplant tourism and commercialism: the Declaration of Istanbul”, (Steering Committee of the Istanbul Summit) 372 The Lancet 5-6 (July 5, 2008).
  • “Governmental Bioethics Commissions: The Nature of the Beast”, in David Sternberg, ed., Biomedical Ethics: A Multidisciplinary Approach to Moral Issues in Medicine and Biology 326-29 (University Press of New England: Hanover, NH, 2007).
  • “Posthumous Sperm Retrieval”, in David Sternberg, ed., Biomedical Ethics: A Multidisciplinary Approach to Moral Issues in Medicine and Biology 269-71 (University Press of New England: Hanover, NH, 2007).
  • “Imagining a New World: Using Internationalism to Overcome the 10/90 Gap in Bioethics”, 21 Bioethics 409-12 (2007).
  • “Ethical Considerations in International Preparedness Planning Efforts”, in S.M. Lemon, et al., eds., Ethical and Legal Considerations in Mitigating Pandemic Disease 157-176 (Washington, DC: National Academies Press, 2007).
  • “International perspectives on the ethics and regulation of human cell and tissue transplantation” (with A. Schulz-Baldes & N. Biller-Andorno), 85 Bull. World Health Org. 941-948 (2007).
  • “Foreword: Why Bother with Ethics in Biomedical Research?” in M. Häyry, T. Takala & Peter Herissone-Kelly, eds., Ethics in Biomedical Research: International Perspectives xi-xii (Amsterdam & New York: Rodofi, 2007).
  • “Addressing an Ethical Dilemma Dialogically Rather than (Merely) Logically”, 6 Am. J. Bioethics 36-38 (2006).
  • “Experimentation with Human Beings: Light or Only Shadows?” 6 Yale J. Health Policy, Law & Ethics 431-49 (2006).
  • “The Dog in the Night-Time; or, the Curious Relationship of the Belmont Report and the President’s Commission”, in J.F. Childress, E.M. Meslin & H.T. Shapiro, eds., Belmont Revisited: Ethical Principles for Research with Human Subjects (Georgetown University Press, 2005).
  • “Ethical Aspects of Major Increases in Life Span and Life Expectancy.” In Coping with Methuselah: The Impact of Molecular Biology on Medicine and Society (Henry J. Aaron and William B. Schwartz, eds.) (Brookings Institution Press, 2004).
  • "Bernard Dickens: Bespoke Public Health, Law and Ethics." 32 Journal of Law, Medicine and Ethics 549 (2004).
  • "When Experiments Go Wrong: The U.S. Perspective." 15 Journal of Clinical Ethics 22 (2004).
  • "Governmental Bioethics Commissions: The Nature of the Beast." 9 Medical Ethics 4 (Fall 2002).
  • "Placing a Moratorium on Research Cloning to Ensure Effective Control over Reproductive Cloning." 53 Hastings Law Journal 1057 (2002). - (Hein)
  • "Punishing Reproductive Choices in the Name of Liberal Genetics." 39 San Diego Law Review 683 (2002). - (Hein)
  • "Stem Cell Politics: The New Shape to the Road Ahead." 2 American Journal of Bioethics 35 (Winter 2002).
  • "Remember Asilomar?: Reexamining Science's Ethical and Social Responsibility" (with R. Schapiro). 44 Perspectives in Biology and Medicine 162 (2001).
  • "Stem Cells: Ethics, Law and Politics." 20 Biotechnology Law Report 678 (2001).
  • "Brain Death - Well Settled Yet Still Unresolved." 344 New England Journal of Medicine 1244 (April 19, 2001).
  • "Reexamining Organ Transplantation." 285 JAMA 334 (January 17, 2001).

Other Works

  • “Field Notes: Jay Katz, 1922-2008”, 39 Hastings Center Report, No. 1, p. ii (Jan.-Feb. 2009).
  • “For the Record” (issues in storage of personal data), 1 Deliberations (USC Law) 6-7 (#2, Winter 2009).
  • “For the Record” (legal update on surrogate motherhood), 1 Deliberations (USC Law) 5 (#1, Summer 2008).
  • “Designing an Equitable Strategy for Allocating Antiretroviral Treatments” (with Andreas Reis). 2 PLoS Medicine 193 (2005).
  • “The Transplant Miracle Still Holds Many Perils Fifty Years Later” (with Luc Noel). The International Herald Tribune, December 30, 2004, at 6.
  • "Stop, Think, but Don't Ban Cloning." Los Angeles Times, November 28, 2001, at B13.
  • "Letter to the Editor." 285 JAMA 1958 (April 18, 2001).
  • "Mapping Our Genomes May Lead to Battles About Use of the Findings (Not the Holy Grail of Biology)." Los Angeles Daily Journal, July 6, 2000, at 6.
  • "End Hypocrisy on Stem Cell Tests." Los Angeles Times, May 2, 2000, at B9.
  • "Body Body Double: Cloning Humans Still a Distant Fantasy." Boston Globe, January 11, 1998, at C1. [Reprinted as "Body Body Double: Cloning Infants a Distant Fantasy" in Writing and Reading Across the Curriculum, 7th Edition and in Writing and Reading in the Disciplines. (Pearson Custom Publishing, 2000).]
  • "Ethical and Human Rights Issues in Research on Mental Disorders That May Affect Decision-Making Capacity." 340 New England Journal of Medicine 1430 (May 6, 1999).
  • "Science, Ethics and Public Policy: Responding to Developments in Embryonic Stem Cells." In IMSUT Symposium for Stem Cell Biology: Proceedings (Institute of Medical Science, 2000).
  • "Slow Down the Rush to Human Cloning." Los Angeles Times, February 13, 1998, at B9. [also published in Buffalo News, February 22, 1998, at H4, and Cleveland Plain Dealer, February 28, 1998, at 10B.]
  • "Stop Any Rush to Clone Human Beings." Newsday, February 18, 1998, at A41.
  • "Add Ethics to the Business of Medicine; Medical School: New Doctors Need Training in the Cost Factor for Treatment, But the Patient's Welfare Must Come First." Los Angeles Times, July 10, 1997, at B9.
  • Cloning Human Beings: Report and Recommendations of the National Bioethics Advisory Commission (The Commission, July 1997).
  • "Counting Sheep: A Presidential Commission Grapples with Issues in Regulating Human Cloning." USC Law 4 (Fall 1997).
  • "Perspective on Medical Ethics: Medicare Won't be Swamped with Pregnancy Claims; A 63 Year-Old Woman Giving Birth Should Spur a Debate, Not a Law, About Reproduction Technology." Los Angeles Times, April 25, 1997, at B9.
  • "The Clinton Health Plan: A Legal Response." The National Law Journal, October 11, 1993, at S18.
  • "Existing Statutes May Not Stop Health Plans from Discriminating Through Selective Marketing." The National Law Journal, October 11, 1993, at S18.
  • "Be Sure to Read the Fine Print: Will California Legalize Euthanasia?" (with Vicki Michel). Commonweal, September 25, 1992, at 16.
  • "Death by Inches in the Dreamcrossed Twilight: Reflections on the Law of Life-Sustaining Treatment." USC Law 2 (Fall 1991).
  • "Perspective on Medicine; Go Easy on Patient Empowerment; Being Hospitalized Now Means Hearing About Life-Support Options; This Shouldn't be a Bureaucratic Terror." Los Angeles Times, December 3, 1991, at 7.
  • "The Clinton Health Plan: A Legal Response." The National Law Journal, October 11, 1993, at S18.
  • "Existing Statutes May Not Stop Health Plans from Discriminating Through Selective Marketing." The National Law Journal, October 11, 1993, at S18.
  • "Be Sure to Read the Fine Print: Will California Legalize Euthanasia?" (with Vicki Michel). Commonweal, September 25, 1992, at 16.
  • "Death by Inches in the Dreamcrossed Twilight: Reflections on the Law of Life-Sustaining Treatment." USC Law 2 (Fall 1991).
  • "Perspective on Medicine; Go Easy on Patient Empowerment; Being Hospitalized Now Means Hearing About Life-Support Options; This Shouldn't be a Bureaucratic Terror." Los Angeles Times, December 3, 1991, at 7.
  • Letter, "Potential for Bias in Economic Analyses" (with M.S. Donaldson). 325 New England Journal of Medicine 1384 (1991).
  • Letter, "Criteria of Death." 16 Journal of Medical Ethics 167 (1990).
  • "The Worth of One Short Life." Baltimore Sun, May 11, 1990.

Testimony

  • U.S. Congress. Senate Committee on Labor and Human Resources. Biomedical Ethics and U.S. Public Policy. Hearings, 103rd Cong., 1st sess., October 14, 1993.
  • U.S. Congress. House Committee on Appropriations, Subcommittee on the Legislative Branch. Legislative Branch Appropriations for 1990. Hearings, 101st Cong., 1st sess., January 30, 1989 and February 2, 1989.
  • U.S. Congress. House Committee on Science and Technology. Subcommittee on Investigations and Oversight. Human Embryo Transfer. Hearings, 98th Cong., 2d sess., August 8, 1984.
  • U.S. Congress. House Select Committee on Aging, Subcommittee on Health and Long-Term Case. The Crisis in Health Care. Hearings, 98th Cong., 1st sess., May 5, 1983.
  • U.S. Congress. House Committee on Science and Technology, Subcommittee on Investigations and Oversight. The Procurement and Distribution of Human Organs for Transplantation. Hearings, 98th Cong., 1st sess., April 14, 1983.
  • U.S. Congress. House Committee on Science and Technology, Subcommittee on Investigations and Oversight. Human Genetic Engineering. Hearings, 97th Cong., 2d sess., November 16, 1982.
  • U.S. Congress. House Committee on Science and Technology, Subcommittee on Investigations and Oversight. Genetic Screening in the Workplace. Hearings, 97th Cong., 2d sess., October 1982.
  • U.S. Congress. House Committee on Energy and Commerce, Subcommittee on Health and the Environment. Health Research Act of 1982. Hearings, 97th Cong., 2d sess., April 23, 1982.
  • U.S. Congress. Senate Committee on Labor and Human Resources, Subcommittee on Investigations and Oversight. Oversight of the National Cancer Institute, 1981. Hearings, 97th Cong., 1st sess., November 3, 6, 1981.
  • U.S. Congress. House Committee on Science and Technology, Subcommittee on Investigations and Oversight, Subcommittee on Health and the Environment. National Cancer Institute's Therapy Program. Joint Hearing, 97th Cong., 1st sess., October 27, 1981.